The gut microbiome's role in GLP-1 regulation is an active area of research, with emerging evidence suggesting that microbial diversity and specific bacterial strains may influence incretin hormone secretion, but more human studies are needed to establish clinical significance
Fasting glucose normalization, improved insulin sensitivity, and better lipid profiles were observed across dose groups, with particular significance at 4mg and above
Channel players With what capabilities (e.g., digital engagement, adherence programs) can we differentiate ourselves as the key enabling partner for leading GLP-1 players
Pratley RE, Aroda VR, Lingvay I, et al
Bierhaus, A
The effects of the active forms of GLP-1 are mediated by a G protein-coupled receptor, GLP-1R, which is expressed in several sites, including enteric and vagal nerves, the stomach, pancreas, intestine, and various brain regions [15]